Therapeutics: Ribosomal protein S6 kinase 70kDa polypeptide 1 (RPS6KB1; S6K1)

Cancer

INDICATION: Acute myelogenous leukemia (AML)

In vitro and mouse studies suggest inhibiting RPS6KB1 could

Read the full 135 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE